Saturday, September 19, 2020

Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Five Stocks To Buy: Federal Bank, GAIL, Eicher Motors And More | June 16, 2026

Market analysts and brokerage firms have identified high-conviction trading ideas for the upcoming session, focusing on private banking, ene...